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Background: Weight loss and loss of fat-free mass (FFM) are associated with peripheral muscle wasting in cystic fibrosis (CF) although
whether this co-exists with loss of diaphragm mass remains unclear.
Methods: FFM was determined by dual-energy X-ray absorptiometry and bioelectrical impedance in 40 adults with CF and 30 age-matched
healthy subjects (HS). Diaphragm thickness at functional residual capacity (FRC) [TDIrel] and total lung capacity (TLC) [TDIcont] and
thickening ratio (TR) were assessed by ultrasonography. Inspiratory muscle strength and work capacity were determined by maximal
inspiratory pressure (PImax), and sustained PImax (SPImax); pulmonary function (RV, VC and TLC) and physical activity status (PAS) were
also determined.
Results: When the CF patients were assessed as a group (low and normal FFM) they had similar age, weight, height and PAS compared to
the HS, although patients had lower FFM ( pb0.05), VC and TLC than the HS ( pb0.01). In addition, although PImax, TDIrel, TDIcont and
TR were similar between the patients and the HS, SPImax was lower in the patients ( pb0.01). When analyses were made between patients
with low versus normal FFM and between patients with low FFM and HS no significant differences were found between overall weight
although TDIrel, TDIcont, TR and PAS were all reduced in patients with low FFM ( pb0.01).
Conclusions: PImax is relatively well preserved in adults with CF although there is a relationship between the loss of inspiratory muscle
work capacity, FFM, PAS and pulmonary function. Furthermore loss of FFM is associated with loss of diaphragm muscle mass.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Body composition; Diaphragm thickness; Cystic fibrosisAbbreviations: BMI, body mass index (kg/m2); CF, cystic fibrosis; CRP, C-reactive protein (μg/ml); DXA, dual-energy X-ray absorptiometry; FEV1, forced
expiratory volume in 1 s (% predicted); FFM, fat-free mass (kg); FRC, functional residual capacity (litres); HS, healthy subjects; PAS, physical activity status
(MET's); PImax, maximal inspiratory pressure (cm H2O); RV, residual volume (litres); SPImax, sustained maximal inspiratory pressure (pressure/time units);
TDIcont, diaphragm thickness measured by ultrasound at total lung capacity (mm); TDIrel, diaphragm thickness measured by ultrasound at functional residual
capacity (mm); TR, thickening ratio (%); TLC, total lung capacity (litres); VC, vital capacity (litres).
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Table 1
Body composition, diaphragm thickness and inspiratory muscle function in
cystic fibrosis (CF) patients and in healthy subjects
Variables CF patients (n=40) Healthy subjects (n=30)
Age (years) 22.4 (21.2–23.6) 21.7 (20.3–23.1)
Height (cm) 166 (160.1–171.9) 168 (164.4–171.6)
Weight (kg) 60.2 (58.5–62.0) 64.4 (60.9–67.9)
BMI (kg/m2) 22.0 (21.0–23.0) 23.0 (22.2–23.8)
FFM (kg) 44.6 (38.6–50.6) 56.8 (49.8–63.8) a
PAS (MET's) 37.0 (35.0–39.0) 41.5 (40.0–43.0)
FEV1 (% pred) 46.5 (46–47) 96.2 (95.2–97.2)
a
VC (litres) 3.6 (3.3–3.9) 4.1 (3.7–4.5) a
RV (litres) 1.7 (1.6–1.8) 1.5 (1.4–1.6)
FRC (litres) 2.6 (2.2–3.0) 2.9 (2.6–3.1)
TLC (litres) 4.6 (4.2–5.0) 5.8 (5.6–6.0) a
Diaph (TDIrel) (mm) 2.8 (2.6–3.1) 3.4 (3.0–3.8)
Diaph (TDIcont) (mm) 3.9 (3.6–4.2) 4.4 (4.2–4.6)
TR (%) 2.7 (2.4–3.0) 2.9 (2.7–3.2)
PImax (cm H2O) 116 (109–123) 124 (119–129)
SPImax (PTU) 609 (543–675) 788 (733–843) a
Data are presented as mean (95% CI). FFM=fat-free mass. PAS=physical
activity status (in MET's=metabolic equivalents [1 MET=3.5 ml/kg/min]),
TDIrel and TDIcont=diaphragm thickness at FRC (rel) and at TLC (cont).
TR=diaphragm thickening ratio (%). PImax=maximum inspiratory pres-
sure. SPImax=sustained maximum inspiratory pressure. PTU=pressure
time units.
a pb0.01.
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Growth retardation and undernutrition are often seen in
patients with cystic fibrosis (CF) as a result of several factors
including malabsorption [1,2], reduced energy intake [3],
increased energy expenditure [4,5] and the inflammatory state
secondary to chronic pulmonary infection [6]. Such events
lead to loss of fat mass and fat-free mass (FFM). The loss of
FFM leads to a reduction in skeletal muscle mass that may co-
exist with inspiratory muscle wasting and loss of inspiratory
muscle function [7,8]. Furthermore patients with low FFM
have been shown to have low levels of physical activity [9] and
the loss of body mass has been shown to be a significant
predictor of survival, a factor independent of pulmonary func-
tion and gas exchange [10].
Although evidence exists that the inspiratory muscles may
be affected by the general loss of muscle mass and despite the
diaphragm being the largest and most important muscle of
inspiration, the effect of loss of FFM on diaphragm thickness
remains unclear. Indeed it has been suggested that diaphragm
bulk is maintained in CF [11], even in the face of peripheral
muscle atrophy [12]. The most widely held hypothesis for this
phenomenon is the presence of a training effect on the
respiratory muscles [11,13] due to the loads imposed by
chronic hyperinflation and increased work of breathing as
indices of inspiratory muscle strength, measured by non inva-
sive methods, appear to be well preserved in CF patients.
However, the assessment of volitional techniques to measure
muscle strength is especially sensitive to the level of effort
exerted [14] and may therefore be strongly influenced by the
subject's ability and motivation. Also, the large intra subject
variability of diaphragm thickness observed in some studies
[11,12] indicates that the beneficial response to an increased
workload on the inspiratory muscles does not occur in all CF
patients. In addition, the different clinical profiles of the
patients in terms of respiratory impairment and nutritional
status make it difficult to interpret studies which have assessed
diaphragm bulk [11,12].
The aim of this study was to investigate the effect of loss of
fat-free mass on pulmonary function, physical activity and
diaphragm thickness in patientswithCF. In order to investigate
these aims, patients with low versus normal fat-free mass were
compared with a group of healthy age-matched controls. The
relationships between fat-free mass, diaphragm thickness,
physical activity status, lung function and indices of inspi-
ratory muscle endurance were also determined.
2. Methods and materials
2.1. Subjects
Forty adult CF patients (22 males) with proven CF and 30
age-matched healthy subjects (15 males) were studied. Mean
age of the patients was 22.4 (age range, 18–32 years); mean
age of the healthy subjects was 21.7, (age range, 18–33 years)
(Table 1). Patients were excluded from the study based on thefollowing criteria: liver cirrhosis, cor pulmonale or an exac-
erbation of their respiratory symptoms (increased respiratory
symptoms, weight loss, fever, or reduction in FEV1 of N10%
than the usual value) or elevated C-reactive protein (N15.5 μg/
ml). None of the patients had obvious signs of malabsorption;
all had pancreatic insufficiency andwere taking supplementary
pancreatic enzyme products with meals. All healthy subjects
were non-smokers, had no evidence of pulmonary pathology
(e.g. asthma) or were suffering from any known metabolic or
endocrine disorder. An adequate sample sizewas found to be at
least 10 subjects per group at α=0.05 and 1β=90%. All
subjects were informed of the nature of the study and gave full
written consent prior to the study which had Research Ethics
Committee approval.
2.2. Study design
This was an observational, cross-sectional study comparing
40 CF patients to 30 healthy subjects (controls). Following this
analysis the CF patients were classified as having either severe
(mean FEV1 36.7 and FFM 36.2 kg respectively) or moderate
disease (mean FEV1 56.3 and FFM 53.0 kg respectively) and
analysed separately with the controls. At the initial screening
visits, in all patients and controls, body composition, pul-
monary function and physical activity status were determined.
In addition, all subjects had an assessment of their inspiratory
muscle function and diaphragm thickness (Table 1). All
measurements of these variableswere obtained by personswho
were blinded to the nature of the study.
Table 2
Body composition and physical activity scores for cystic fibrosis patients
with low and normal fat-free mass (FFM) and healthy subjects a
Variable CF patients low FFM
(n=22)
Patients normal
FFM (n=18)
Healthy subjects
(n=30)
Age (years) 22.3 (20.7–23.9) 22.6
(20.6–24.6)
21.7 (20.3–23.1)
Height (cm) 162 (158.0–166.0) b, c 168
(162.7–172.3)
168 (164.4–171.6)
Weight (kg) 58.6 (55.2–62.0) 62.1
(57.4–66.8)
64.4 (60.9–67.9)
BMI (kg/m2) 21.5 (20.7–22.3) b, d 22.4
(21.0–23.8)
23.0 (22.2–23.8)
FFM (kg) 36.2 (29.2–43.2)b,d 53.0
(45.0–61.0)c, e
56.8 (49.8–63.9)
PAS (MET's) 33.0 (29.9–36.1)b,c 41.1
(40.6–41.6)
41.5 (40.0–43.0)
CRP (μg/ml) 7.5 (6.8–8.2) 6.9 (6.4–7.4)
a Data are presented as mean (95% CI). FFM=fat-free mass. PAS=phy-
sical activity status (in MET's=metabolic equivalents [1 MET=3.5 ml/kg/
min]). CRP=C-reactive protein.
b Patients with low FFM had significantly lower values in these variables
than patients with normal FFM or healthy subjects.
c pb0.01.
d pb0.05.
e Patients with normal FFM had significantly lower values in these
variables than healthy subjects.
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Weight (kg) and height (cm) were determined using a
stadiometer (cm) (accurate to 1.5mm) (Holtain Ltd, Crosswell,
UK) and an electronic balance (Mott electroscale, model LC
2424, UK). Body mass index (BMI) was calculated (kg/m2).
2.4. Dual energy X-ray absorptiometry (DXA)
In all CF whole body DXA scans (Hologic QDR200+,
Hologic IncWaltham,MA, USA) were performed 2 h before a
meal andwith an empty bladder. Subjects were scanned supine
using a pencil beammode, enhanced software, and a calculated
radiation dose of 4.6 μSv. Each scan took 15–20 min. The
coefficient of variation (CV) of the Hologic QRD 2000+ for
whole body calculation was 0.4–1.0% [15]. FFM obtained
from the healthy subjects was within the limits of a healthy UK
population of the same age and sex, although these data were
generated from bioelectrical impedance. Two groups of CF
patients were defined according to FFM by DXA; (1) low
FFM if less than the fifth percentile for the healthy subjects;
(2) normal FFM if greater than the fifth percentile for the
healthy subjects [16,17].
2.5. Diaphragm thickness
The coefficient of reproducibility (CR) of diaphragm
thickness measured by ultrasound at functional residual
capacity (FRC) (TDIrel) and TLC (TDIcont) was calculated
from an examination of both within and between subject
variations between measurements using analysis of variance
models [18]. These were determined to be 90% and 91%
respectively. In all subjects, diaphragm thickness (mm) was
assessed by B-mode ultrasonography using a 7.5 MHz linear
transducer (PLE 705S Toshiba Medical System, Japan) at the
zone of apposition in either the eighth or the ninth intercostal
space as described by De Bruin et al. [19]. In order to allow
for possible alterations in lung volume due to gas trapping
from an increase in airways resistance, the FEV1/FVC ratio
was measured in order to determine that all measurements of
diaphragm thickness were obtained at the same lung volume.
The mean of three measurements was recorded by a single
experienced reader. In order to standardise for any change in
lung volume during these three estimations, the diaphragm
thickening ratio (TR) was determined by the formulae of
Ueki et al. [20].
2.6. Lung function
Three trials were conducted for each of the lung function
measurements (FEV1, FVC and FEV1/FVC ratio) by dry
wedge spirometry. The highest value was used as the
representative score for each subject (Vitalograph Ltd.,
Bucks, UK); TLC, RV, RV/TLC, and FRC were obtained
by helium dilution using a previously described wash-in
technique [21].2.7. Circulating C-reactive protein
Clinical stability was assessed by assessment of serum
concentrations of C-reactive protein (CRP) which was deter-
mined by sandwich enzyme-linked immunosorbent assay with
goat and rabbit anti-human CRP and anti-rabbit IgG-alkaline
phosphatase conjugate [22] (Table 2).
2.8. Physical activity status
This was determined in all subjects using a recall question-
naire relating to physical activity in the preceding month. The
activity score was expressed in METS (1 MET=the energy
expended by a person at rest [1 MET=3.5 ml/kg/min]) [23].
2.9. Inspiratory muscle function
The coefficient of reliability (CR) values for measure-
ments of maximum and sustained maximum inspiratory
pressure (PImax and SPImax) were previously established to
be 89% and 90% respectively [24]. PImax was determined
using an electronic manometer and computer software. The
manometer had a fixed leak via a 2 mm-diameter aperture
that prevented glottal closure during the inspiratory ma-
noeuvre [25] and set a maximum flow during the inspiratory
effort proportional to the pressure achieved. The leak set a
maximum during the inspiratory effort and allowed contin-
uous measurement of pressure over a full range of lung
volumes until no further pressure could be generated. This
measure of work was termed sustained maximum inspiratory
pressure (SPImax) [26]. The patient was asked to take a
Table 3
Lung function, inspiratory muscle function and diaphragm thickness for
cystic fibrosis (CF) patients with low and normal fat-free mass and healthy
subjects a
Variable CF patients low
FFM
(n=22)
CF patients
normal FFM
(n=18)
Healthy
subjects
(n=30)
FEV1 (% pred) 36.7
(36.1–37.4) b, c
56.3
(55.8–56.8) c, d
96.2
(95.2–97.2)
VC (litres) 3.1 (2.9–3.3)b,c 4.0 (3.8–4.2)d, e 4.1 (3.2–4.5)
RV (litres) 1.8 (1.6–2.0) 1.6 (1.4–1.8) 1.5 (1.4–1.6)
TLC (litres) 4.1 (3.9–4.3)b,c 5.1 (4.9–5.3)d,e 5.8 (5.5–6.0)
FRC (litres) 2.5 (2.1–2.9) 2.8 (2.2–3.4) 2.9 (2.6–3.1)
Diaph (TDIrel)
(mm)
2.3 (2.0–2.6)b,c 3.2 (2.7–3.7) 3.4 (3.0–3.8)
Diaph (TDIcont)
(mm)
3.3 (3.1–3.5)b,c 4.3 (3.9–4.7) 4.4 (4.2–4.6)
TR (%) 2.4 (2.3–2.5)e 2.8 (2.6–2.8) 2.9 (2.7–3.2)
PImax (cm H2O) 109 (100 –118)
b,c 119 (111–127)d,e 124 (119–129)
SPImax (PTU) 520 (462–584)b,c 698 (634–762)d,e 788 (733–843)
a Data are presented as mean (95% CI). TDIrel and TDIcont=diaphragm
thickness at FRC (rel) and at TLC (cont). TR=diaphragm thickening ratio
(%). PImax=maximum inspiratory pressure. SPImax=sustained maximum
inspiratory pressure. PTU=pressure time units.
b Patients with low FFM had significantly lower values in these variables
than patients with normal FFM or healthy subjects.
c pb0.01.
d Patients with normal FFM had significantly lower values in these
variables than healthy subjects.
e pb0.05.
Table 4
Correlation coefficients between measured variables of body composition,
diaphragm thickness, physical activity status, pulmonary function and
C-reactive protein in patients with cystic fibrosis (n=40)
Variables Pearsons correlation coefficient (r)
Height (cm) vs TDIcont (mm) +0.273 a
Height (cm) vs SPImax (PTU) +0.418 b
BMI (kg/m2) vs TDIcont (mm) +0.302 a
PImax (cm H2O) vs TDIcont (mm) +0.348
a
SPImax (PTU) vs TDI cont (mm) +0.444 a
FFMI (kg/m2) vs TDIcont (mm) +0.316 a
FFMI (kg/m2) vs SPImax (PTU) +0.254 b
BMI (kg/m2) vs SPImax (PTU) +0.273 b
FFM (kg) vs SPImax (PTU) +0.370 a
PAS vs VC (litres) +0.334 a
PAS vs TLC (litres) +0.420 a
CRP (μg/ml) vs FFMI (kg/m2) +0.332 a
TDIcont=diaphragm thickness at TLC. TR=diaphragm thickening ratio.
PImax=maximum inspiratory pressure. SPImax=sustained maximum inspi-
ratory pressure. PTU=pressure time units. FFM=fat-freemass. PAS=physical
activity status (in MET's=metabolic equivalents [1 MET=3.5 ml/kg/min]).
CRP=C-reactive protein.
a pb0.05.
b pb0.01.
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volume (RV) to TLC, and pressure (cm H2O) was recorded
over time by a computer. PImax was the maximum pressure
developed in the first second of inspiration; SPImax was
measured as the area under the pressure–time curve [26].
2.10. Statistical analysis
Prior to all the analyses, normality of the data for all
measured variables was assessed by the one-sample Kolmo-
gorov–Smirnov test. Data not normally distributed were
log10 transformed. All data are presented as means and as
95% confidence intervals. Differences in the study group
characteristics between the patients and healthy subjects were
analysed using t-tests. Differences between patients with low
versus normal FFM and healthy subjects were analysed using
a one-way analysis of variance and post hoc Tukey tests.
Relationships between variables were assessed using Pear-
son's correlations. All statistical calculations were performed
using the Statistical Package for the Social Sciences (SPSS)
for Windows, version 12 and significance was set at pb0.05.
3. Results
3.1. Body composition: patients comparedwith healthy subjects
When the 40 CF patients were expressed as a group (low
and normal FFM) the patients had similar age, weight,
height, physical activity status (PAS) and BMI compared tothe healthy subjects, although the patients had lower values
of FFM, FEV1, VC and TLC ( pb0.01). In addition to this,
although PImax, relaxed and contracted diaphragm thickness
(TDIrel and TDIcont) and thickening ratio (TR) were similar
between the CF patients, the healthy subjects SPImax was
found to be lower in the patients with CF ( pb0.01) (Table 1).
3.2. Body composition: between patient comparisons
There were 18 patients with moderate disease (mean FEV1
56.3 and FFM 53.0 kg respectively) and 22 patients whose
disease was categorised as severe (mean FEV1 36.7 and FFM
36.2 kg respectively). When analyses were made between
patients within these categories, there were no significant
differences found between age and weight although height,
BMI, and PAS were all lower in the patients with low FFM
(Table 2). Patients with a low FFM also had a reduced FEV1
(% pred), VC ( pb0.01), TLC ( pb0.05) and a reduced PImax
and SPImax ( pb0.01). These findings were consistent with a
reduction in both TDIrel and TDIcont ( pbb0.01) and (TR)
( pb0.05) (Table 3).
3.3. Relationships between body composition, C-reactive
protein, diaphragm thickness, and inspiratory muscle
function in patients with cystic fibrosis
When the CF patients were analysed as a whole group (no
separation for low versus normal FFM), there were significant
positive correlations between height, and TDIcont (pb0.05)
and TDIcont and BMI (pb0.05). TDIcont also correlated with
PImax, SPImax and FFM (pb0.01). In addition to this,
significant relationships were identified between SPImax and
BMI (pb0.05) and SPImax and FFM and FFM andC-reactive
protein (pb0.01). Lower levels of PAS were also shown to be
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ficant correlations for the whole group of patients with CF
were identified between variables of TDIrel, FFM, PAS or
PImax and SPImax (Table 4).
4. Discussion
The present study has shown that (1) CF patients with
severe pulmonary disease and low FFMhave poor inspiratory
muscle work capacity and function capabilities and reduced
diaphragm thickness when compared to CF patients with a
normal FFM, (2) CF patients with a normal FFM do not have
significantly different inspiratory muscle function, measured
as PImax or SPImax, or diaphragm thickness when compared
to age-matched healthy subjects, (3) the findings of poor
pulmonary function and body composition are consistent
with a significant reduction in physical activity, relaxed and
contracted diaphragm thickness and thickening ratio in CF
patients.
Diaphragm muscle mass is related to an individuals height
and weight [27], and loss of as much as 30% of predicted body
weight has been found to be associated with a reduction in
diaphragm mass, thinning of the muscle, and a reduction in its
area [28,29]. This has been shown to be related to sarcomere
loss with a reduction in diaphragmatic thickness in malnour-
ished patients with COPD [29] and that in cachetic subjects the
reduction in body weight is associated with a decreased
contractility of the diaphragm and hence increasing the risk of
respiratory failure [30]. Similar studies in severely malnour-
ished CF patients have not been available for comparison as in
previous investigations no separation was made for patients
with low versus normal FFM [11–13] and the degree of
malnutrition has been modest. This lack of separation in terms
of disease severity may also account for the high intersubject
variability in diaphragm thickness in previous studies as
examination of the data in Table 1 demonstrates relatively
small variability and no significant difference in diaphragm
thickness between patients when compared with the healthy
subjects despite small but significant differences in FFM. This
is in contrast to the findings when patients were separated into
moderate versus severe disease as appreciable differenceswere
demonstrated in both relaxed and contracted diaphragm
thickness andwhichwas associatedwith significant reductions
in PImax and single breath work capacity (SPImax).
The preservation of volitional tests of inspiratory muscle
strength and diaphragm thickness in patients with CF in
previous investigations has been postulated to be the result of
a selective ‘training stimulus’ as the load on the inspiratory
muscles is increased due to the effects of hyperinflation in
patients with chronic lung disease [11–13]. Although the
diaphragm has been shown to increase its thickness during
training with both respiratory [31,32] and non-respiratory
manoeuvres [33,34], this is in contrast to the constant load
exerted by lung disease (hyperinflation and increased work
of breathing). Skeletal muscle training is applied by the
imposition of overload at a specific intensity to obtain astrength or endurance response [35], but requires that this is
followed by unloading and planned adaptation. Loads of
greater than 60% of peak force are not sustainable [36] and
breathing at work levels close to PImax will induce fatigue
rather than a required or planned training response unless the
breathing strategy is altered to avoid fatigue. Therefore the
relative preservation of PImax in patients with hyperinflated
lungs may be an adaptive response to loading of the respi-
ratory muscles from the effects of hyperinflation [37] rather
than a training response. This is in contrast to the findings in
older COPD patients where reductions in PImax are asso-
ciated with an increase in the proportion of type 1 fibres in
the respiratory muscles [38]. This adaptive response allows
tolerance of endurance but at the expense of reduced power/
strength capabilities and may reflect a different time course
of the disease process or reflect differential response to
energy balance between CF and COPD [39].
The finding of decreased work capacity of the inspiratory
muscles as measured by SPImax is in agreement with earlier
investigations, which demonstrated a reduction in the overall
functional capabilities of the inspiratory muscles in malnour-
ished CF patients [26] due to a combination of muscle weak-
ness and lung hyperinflation [40] and loss of diaphragmatic
force as contraction approaches TLC [41,42]. Unlike the
measurement of PImax, SPImax is a measure of pressure
generation over a full range on lung volumes, a manoeuvre
which is more closely correlated with inspiratory muscle
function in CF patients than PImax [26]. The data in the
present study have also identified significant correlations
between SPImax and diaphragm thickness but which were not
evident with measures of PImax. In addition to this, previous
studies of respiratory muscle strength have demonstrated
conflicting results which may be due to the small numbers of
patients included or to differences in disease severity and
hence loss of homogeneity of the study population. This study
attempted to control for this by determining body composition,
pulmonary function and physical activity status in a large
series of patients and comparing these to a group of age-
matched healthy subjects. Consequently the design of the
study allowed for the identification of differences between
groups of CF patients with low versus normal FFM thereby
reducing any inherent intersubject variability.When separation
for body composition was made these findings support the
view that loss of muscle mass is the likely cause of reduced
inspiratory muscle function. However other influences which
adversely affect the contractile properties of the respiratory
muscles include alterations in lungmechanics [40–42], altered
oxygen kinetics and a decrease in aerobic capacity of the
respiratory muscles [43].
No differences in height, weight and therefore body mass
indexwere found between the CF patients when expressed as a
whole group and the healthy subjects although FFM was
reduced in the patients and was associated with poor pulmo-
nary function (Table 1). These findings are consistent with
previous investigations, which found BMI to be normal in
40% of nutritionally depleted CF patients [44] with many CF
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relationship between BMI and the impairment of lung
function. In the healthy subjects FFM was within the limits
of a healthy UK population of the same age and sex, although
these data were generated from bioelectrical impedance.
However, a previous investigation has demonstrated that
there was good agreement between measurements taken by
DXA and BI for measurements of FFM and LBM [6]. The
decline in physical activity in patients with reduced FFM is in
agreement with earlier studies and has been shown to result in
loss of quadriceps muscle bulk [45].
4.1. Limitations of this study
This study could be criticised for only measuring dia-
phragm thickness by ultrasonography as previous investiga-
tions which have assessed diaphragm bulk in CF have used a
combination of methods including twitch transdiaphragmatic
pressure and computed tomographic scanning [11,12]. How-
ever in the present investigation diaphragm thickness was
assessed using a published method [19,20,31] which has
demonstrated excellent reproducibility in the measurement of
both diaphragm [46] and abdominal muscle thickness [47]. A
further limitation of this study is that the heliun dilution
method was used to measure lung function which is known to
underestimate FRC and TLC in patients with airways
obstruction who present with poorly or non-ventilated areas
in the lung [48] and particularly in those patients with very
severe lung disease [49]. As this study compared lung
capacities to those of healthy subjects inaccuracies in these
measurement may have underestimated the severity of lung
disease in the CF patients, particularly those with loss of lean
body mass and worsening pulmonary function.
In summary, this study has shown that diaphragm thick-
ness is relatively well preserved in CF adults with normal
FFM. However the present study suggests that loss of FFM
and worsening pulmonary disease results in loss of inspi-
ratory muscle function and that this is associated with sig-
nificant atrophy of the diaphragm which is closely related to
a reduction in physical activity in CF patients.
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Appendix A
Formulae for the calculation of BMI (kg/m2):
Formulae for the assessment of FFMI=fat-free mass in
kilograms per meter squared (kg/m2):
Formulae for the calculation of the diaphragm thickening
ratio:
TR %ð Þ ¼ Diaphragm thickness during MIP manoeuvre at FRC
Mean thickness while relaxing at FRCFormula for the calculation of reproducibility for dia-
phragm thickness:
CRð%Þ ¼ rB=ðrBþ rW Þ
where σB=between subject variance and σW=within sub-
ject variance.
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